EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeitlinie

Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures

Liliane C Roosendaal iD, Orkun Doganer, Arno M Wiersema, Jan D Blankensteijn, Vincent Jongkind

Vascular · 2025

DOI: 10.1177/17085381241283519 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Vascular, 2025. Verfasst von Liliane C Roosendaal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Dijklander Ziekenhuis, Hoorn, the Netherlands. Hauptthemen laut MEDLINE: Anticoagulants, Blood Coagulation, Drug Monitoring, Heparin. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This systematic review was performed to examine all published practice Guidelines and Consensus Statements (together: GCS) on heparin dosing and monitoring during non-cardiac arterial procedures (NCAP). The objective was to scrutinize the recommendations and advice outlined within these GCS documents and to evaluate the supporting evidence for these recommendations. Additionally, the use of the activated clotting time (ACT) and target ACT values were explored.

Methods

This systematic review was performed in accordance with the PRISMA Guidelines. Medline and Embase databases were searched to identify all GCSs in the English language on NCAP. The final literature search was performed in January 2023. This search was supplemented by searching websites of relevant professional vascular surgical organizations for GCSs. Titles and abstracts were assessed by two independent reviewers.

Results

Of 9716 titles identified, 27 GCSs met the predefined inclusion criteria: six GCSs regarding carotid intervention, seven regarding procedures for aneurysmal disease of the abdominal aorta and iliac arteries, 12 regarding interventions for acute and chronic peripheral arterial occlusive disease and two regarding open and endovascular interventions of thoraco-abdominal aortic aneurysms. Administration of heparin is advised for al NCAP. There was high variability concerning heparin dose: both standard dose as weight based dosing (30-150 IU/kg) was advised. Recommendations on repeated doses, ACT monitoring and heparin reversal using protamine also varied widely. In none of the GCSs, the type of the ACT measuring device or used cartridges were specified.

Conclusions

Large variability was found between the included GCSs with regard to the recommendations on heparin dose and target ACT values during NCAP. Advice and recommendations in GCSs were based on low-quality studies or without providing any reference at all. The described variability in recommendations emphasizes the need for large prospective (randomized) studies or the incorporation of data on heparin and the use of ACT monitoring into verified vascular surgery registries, to develop evidence-based, practical and uniform applicable recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsBlood CoagulationDrug MonitoringHeparinHeparin AntagonistsMonitoring, IntraoperativePractice Guidelines as TopicHumansConsensusEvidence-Based MedicinePredictive Value of TestsProtaminesRisk FactorsTreatment OutcomeVascular Surgical Procedures

Stichwörter der Autor:innen

Heparinactivated clotting timenon-cardiac arterial proceduresvascular surgical procedures

Substanzen

AnticoagulantsHeparinHeparin AntagonistsProtamines

Autor:innen und Institutionen

  • Department of Vascular Surgery, Dijklander Ziekenhuis, Hoorn, the Netherlands.
  • Department of Vascular Surgery, Amsterdam UMC, Amsterdam, the Netherlands.
  • Amsterdam Cardiovascular Sciences, Microcirculation, Amsterdam, the Netherlands.

ORCID-Profile: Liliane C Roosendaal

Zitieren

APA

Roosendaal, L. C., Doganer, O., Wiersema, A. M., Blankensteijn, J. D., & Jongkind, V. (2025). Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures. Vascular. https://doi.org/10.1177/17085381241283519

Vancouver

Roosendaal LC, Doganer O, Wiersema AM, Blankensteijn JD, Jongkind V. Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures. Vascular. 2025. doi:10.1177/17085381241283519

BibTeX
@article{Roosendaal2025,
  author = {Roosendaal, Liliane C and Doganer, Orkun and Wiersema, Arno M and Blankensteijn, Jan D and Jongkind, Vincent},
  title = {Systematic review of clinical guidelines and consensus statements concerning heparin and protamine dosing and monitoring of anticoagulation levels for non-cardiac arterial procedures},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241283519}
}
Kostenlos starten →